SpringLeaf Therapeutics
Latest round
- Series B
Last raised
- Jul 2011
Total raised
- $31M
Investors
- 4
About SpringLeaf Therapeutics
Founded in 2007, SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on convergent science and is designed to enable and differentiate therapeutics.
Who invested in SpringLeaf Therapeutics
4 investors across 3 rounds
See all investors in SpringLeaf Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about SpringLeaf Therapeutics
Who invested in SpringLeaf Therapeutics?
SpringLeaf Therapeutics has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SpringLeaf Therapeutics raised?
SpringLeaf Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did SpringLeaf Therapeutics last raise money?
SpringLeaf Therapeutics's most recent round on record is a Series B, in Jul 2011.
What does SpringLeaf Therapeutics do?
Founded in 2007, SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients.
Where is SpringLeaf Therapeutics headquartered?
SpringLeaf Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like SpringLeaf Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at SpringLeaf Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like SpringLeaf Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.